Statistics
Publications
21
Citations
13.7K
H-Index
16
Active since
2018
Jingxin Fu is an author at Dana-Farber Cancer Institute specializing in cancer immunology, oncology, and cancer immunotherapy.
Publications per year
2018–2025
21
21
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li, Jingxin Fu, Zexian Zeng et al. · Nucleic Acids Research · 2020 · 5.7K citations · Full text
Medicine, Bioinformatics, Oncology +17
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang, Shengqing Gu, Deng Pan et al. · Nature Medicine · 2018 · 5.6K citations · Full text
Life Sciences, Immunology, Oncology +14
Large-scale public data reuse to model immunotherapy response and resistance
Jingxin Fu, Karen Li, Wubing Zhang et al. · Genome Medicine · 2020 · 1.1K citations · Full text
Medicine, Bioinformatics, Oncology +17
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
Shengqing Gu, Wubing Zhang, Xiaoqing Wang et al. · Cancer Discovery · 2021 · 282 citations · Full text
Life Sciences, Immunology, Oncology +16
Landscape of B cell immunity and related immune evasion in human cancers
Xihao Hu, Jian Zhang, Jin Wang et al. · Nature Genetics · 2019 · 221 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 21